Literature DB >> 24431294

ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation.

Stylianos A Pyxaras1, Fabio Mangiacapra, William Wijns, Luigi Di Serafino, Frederic De Vroey, Gabor Toth, Gianfranco Sinagra, Bernard De Bruyne, Guy R Heyndrickx, Emanuele Barbato.   

Abstract

AIM: To assess ACEF (age, creatinine, and ejection fraction) and Clinical SYNTAX (CSS) score in the risk stratification of patients with heavily calcified stenosis undergoing rotational atherectomy with stent implantation (rota-stenting). METHODS AND
RESULTS: ACEF and CSS were calculated in 221 consecutive patients with stable angina undergoing rota-stenting. Mean age of the patients was 74 ± 10 years, left ventricular ejection fraction was 61 ± 18%, and final burr size 1.78 ± 0.24 mm, with 2.6 ± 0.9 burrs used for each patient. Primary end-point was MACE at one-year defined as the composite of cardiac death, myocardial infarction, and target vessel revascularization. Post-hoc analysis was performed by stratifying the clinical outcome according to ACEF and CSS tertiles. At 1 year there was a significantly higher MACE rate in the high tertile of ACEF (24% for ACEFHigh vs. 13% for ACEFMid vs. 9% for ACEFLow; P = 0.017) and CSS (25% for CSSHigh vs. 12% for CSSMid vs. 8% for CSSLow; P = 0.008). The predictive accuracy for both ACEF and CSS was moderate (c-statistics, 0.629 and 0.638, respectively).
CONCLUSION: Both ACEF and CSS predict with moderate accuracy MACE at 1-year in patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ACEF score; calcified coronary stenosis; clinical SYNTAX score; major adverse cardiovascular events; rotational atherectomy

Mesh:

Substances:

Year:  2014        PMID: 24431294     DOI: 10.1002/ccd.25360

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Therapeutic effect of rotational atherectomy with implantation of drug eluting stent in heavily coronary calcified patients.

Authors:  Zhong-Hai Wei; Jun Xie; Lian Wang; Wei Huang; Kun Wang; Li-Na Kang; Jing-Mei Zhang; Jie Song; Biao Xu
Journal:  J Geriatr Cardiol       Date:  2016-03       Impact factor: 3.327

2.  Predictive value of the combination of age, creatinine, and ejection fraction score and diabetes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.

Authors:  Side Gao; Qingbo Liu; Xiaosong Ding; Hui Chen; Xueqiao Zhao; Hongwei Li
Journal:  Coron Artery Dis       Date:  2020-03       Impact factor: 1.717

3.  Predictive value of ACEF score for clinical prognosis of patients with heavily calcified coronary lesions after percutaneous coronary intervention with rotational atherectomy.

Authors:  Hongwu Chen; Xiaofan Yu; Guangquan Qiu; Likun Ma
Journal:  J Cardiothorac Surg       Date:  2022-04-27       Impact factor: 1.522

4.  Outcomes of atherectomy in treating severely calcified coronary lesions in patients with reduced left ventricular ejection fraction: A systematic review and meta-analysis.

Authors:  Waiel Abusnina; Mostafa Reda Mostafa; Ahmad Al-Abdouh; Qais Radaideh; Mahmoud Ismayl; Mahboob Alam; Jaffer Shah; Noraldeen El Yousfi; Timir K Paul; Itsik Ben-Dor; Khagendra Dahal
Journal:  Front Cardiovasc Med       Date:  2022-09-20

5.  Predictive value of the age, creatinine, and ejection fraction score in patients with myocardial infarction with nonobstructive coronary arteries.

Authors:  Side Gao; Wenjian Ma; Sizhuang Huang; Xuze Lin; Mengyue Yu
Journal:  Clin Cardiol       Date:  2021-06-01       Impact factor: 2.882

6.  Correlation between serum free triiodothyronine levels and risk stratification in Chinese patients with acute coronary syndrome receiving percutaneous coronary intervention.

Authors:  Huiying Li; Chunlin Li; Yongyi Bai; Zhao Wang; Man Li; Yulun Cai; Wenli Zhou; Baohua Zhang; Hongbin Liu
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.